Cover - shares	9 Months Ended
	Sep. 30, 2024	Mar. 06, 2025
Cover [Abstract]
Document Type	10-Q/A
Amendment Flag	true
Amendment Description	This Amendment No. 1 to the Quarterly Report on Form 10-Q (“Form 10-Q/A”) of Polomar Health Services, Inc. (the “Company”) amends its Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2024 which was originally filed with the Securities and Exchange Commission on November 19, 2024 (the “Original Form 10-Q”). The changes to the Original Form 10-Q are in response to comments the Company received from the Securities and Exchange Commission relating to (a) certain adjustments to the weighted average number of shares used in the calculations of net loss per common share for the three and nine months ended September 30, 2023, (b) a further explanation of the basis under generally accepted accounting principles for recording fair market value for the acquisition of certain assets and (c) an expansion of the Company’s revenue recognition policy. In addition, certain changes were made to the financial statements, to change the accounting treatment of the Company’s September 30, 2024 acquisition of Polomar Specialty Pharmacy, LLC, a Florida limited liability company (“Polomar”), whereby, among other things, the Company acquired 100% of Polomar in exchange for the issuance of shares of the Company’s common stock, and Polomar became the wholly-owned subsidiary of the Company (the “Acquisition”). The accounting treatment relating to the Acquisition as disclosed in the Original Form 10-Q provided that the Acquisition was a reverse merger with Polomar as the “accounting acquirer” and the Company as the “legal acquirer”, and accordingly the Company accounted for the transaction as a business combination. Instead, the Company and its Board of Directors, determined that the Acquisition was a recapitalization. As required by Rule 12b-15 under the Securities Exchange Act of 1934, as amended, new certifications by the Company’s principal executive officer and principal financial officer are being filed as Exhibits 31.1, 31.2 and 32.1 to this Form 10-Q/A.   Except as described in this Explanatory Note, this Form 10-Q/A does not modify, amend, or update any of the financial information or any other information set forth in the Original Form 10-Q, and this Form 10-Q/A does not reflect events that occurred subsequent to September 30, 2024.
Document Quarterly Report	true
Document Transition Report	false
Document Period End Date	Sep. 30, 2024
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2024
Current Fiscal Year End Date	--12-31
Entity File Number	000-56555
Entity Registrant Name	Polomar Health Services, Inc.
Entity Central Index Key	0001265521
Entity Tax Identification Number	86-1006313
Entity Incorporation, State or Country Code	NV
Entity Address, Address Line One	10940 Wilshire Blvd. Suite 1500
Entity Address, City or Town	Los Angeles
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	90024
City Area Code	(213)
Local Phone Number	616-0011
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		27,657,679